One year in review 2020: comorbidities, diagnosis and treatment of primary Sjogren's syndrome

V Manfrè, G Cafaro, I Riccucci, A Zabotti… - Clinical and …, 2021 - research.rug.nl
Primary Sjogren's syndrome (pSS) is a complex and heterogeneous disorder characterised
by a wide spectrum of glandular and extra-glandular features. The discovery of novel …

The multiple roles of interferon regulatory factor family in health and disease

L Wang, Y Zhu, N Zhang, Y Xian, Y Tang, J Ye… - … and Targeted Therapy, 2024 - nature.com
Abstract Interferon Regulatory Factors (IRFs), a family of transcription factors, profoundly
influence the immune system, impacting both physiological and pathological processes …

Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells

O Erdogan, M Abbak, GM Demirbolat, F Birtekocak… - PloS one, 2019 - journals.plos.org
In this study, we report on the synthesis of silver nanoparticles (AgNPs) from the leaf extracts
of Cynara scolymus (Artichoke) using microwave irradiation and the evaluation of its anti …

Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potential

BK Roberts, G Collado, BJ Barnes - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Canonically, the transcription factor interferon regulatory factor 5 (IRF5) is a key mediator of
innate and adaptive immunity downstream of pathogen recognition receptors such as Toll …

Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells

D Uslu, BI Abas, GM Demirbolat, O Cevik - Molecular Diversity, 2024 - Springer
Exosomes have come to the fore in drug delivery systems due to their biological-based and
immune-suppressing properties. In this study, we investigated the effect of doxorubicin …

Design, synthesis and biological evaluation of some new 2-Pyrazoline derivatives as potential anticancer agents

F Tok, Bİ Abas, Ö Çevik, B Koçyiğit-Kaymakçıoğlu - Bioorganic Chemistry, 2020 - Elsevier
A new series of N-(4-(1-Phenyl-5-aryl-4, 5-dihydro-1H-pyrazol-3-yl) phenyl)-4-
substitutedbenzamide derivatives were designed and synthesized from new chalcone …

[HTML][HTML] IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma

Z Li, M Geng, X Ye, Y Ji, Y Li, X Zhang… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Osteosarcoma (OS) is a malignant bone tumor among adolescents and young adults. IRF7
belongs to the transcription factor family of interferon regulatory factors (IRFs) and has …

Therapeutic targeting of IRFs: pathway-dependence or structure-based?

CD Thompson, B Matta, BJ Barnes - Frontiers in immunology, 2018 - frontiersin.org
The interferon regulatory factors (IRFs) are a family of master transcription factors that
regulate pathogen-induced innate and acquired immune responses. Aberration (s) in IRF …

IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation

BK Roberts, DI Li, C Somerville, B Matta, V Jha… - Scientific Reports, 2024 - nature.com
Metastasis is driven by extensive cooperation between a tumor and its microenvironment,
resulting in the adaptation of molecular mechanisms that evade the immune system and …

[HTML][HTML] IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE

D Li, B Matta, S Song, V Nelson, K Diggins… - JCI insight, 2020 - ncbi.nlm.nih.gov
Genetic variants within or near the interferon regulatory factor 5 (IRF5) locus associate with
systemic lupus erythematosus (SLE) across ancestral groups. The major IRF5-SLE risk …